Overview


Jana Grieb specializes in health care and life sciences, with a particular focus on the pharmaceutical and medtech industry.Jana has advised numerous pharmaceutical and medical devices companies in a variety of regulatory issues, transactions and contractual matters across the European Union, and has represented them in litigation with regard to public procurement law, unfair competition and reimbursement by public and private payers.

Show More

Results


  • Advising German and international pharmaceutical companies and medical devices manufacturers on the regulation of advertising and promotion of medicinal products and medical devices, as well as on compliance with national and European codes of conduct
  • Advising pharmaceutical companies and medical devices companies in transactions
  • Advising German and international pharmaceutical companies and medical devices manufacturers on distribution, licensing, co-promotion and clinical trials

Show More

Recognition


  • Leaders League’s 2019 guide, Innovation, Technology & Patents, “Excellent” in the Health, pharma & biotechnology category
  • Chambers Europe 2015 to 2019, Healthcare & Life Sciences-Germany
  • The Legal 500 EMEA 2019

Community


  • German Lawyers’ Association, Working Group for Medical Law
  • German Federal Association for the Pharmaceutical Industry

Credentials


Education
Nottingham Law School, LLM, 2005
Higher Regional Court of Frankfurt, Second State Exam, 2001
Universities of Gießen and Regensburg, First State Exam, 1998

Admissions
Germany

Show More

Jana Grieb

Insights & Events / Media

Shanghai, China / McDermott Event / December 5, 2018

Pharm. Ind. 80, Issue 10 / November 2018

Cambridge, Massachusetts / McDermott Event / September 12, 2018

Copenhagen, Denmark / Speaking Engagements / June 12, 2018

Washington, District of Columbia / Speaking Engagements / May 3-4, 2018

Cyber Security Law & Practice: Volume 2, Issue 4 / April 2016

The Chilling Ransomware Threat Facing Hospitals

Cyber Security Law & Practice (London) / April 2016

PharmaRecht, Issue 4 / April 30, 2015

Comparable Drugs in Price Negotiations Under Sec. 130b SGB V

International Law Office Newsletter, Germany / October 29, 2014

German Perspective on New EU Clinical Trials Regulation

VC Magazine / April 23, 2014

Legal Framework for Health Apps

eHealth Law & Policy, Volume 1, Issue 2 / March 2014

Germany Further Liberalises Pharma Advertising Online

Healthcare Marketing - Das Fachmagazin für Gesundheitsmarken, Issue 1-2 / January 2014

Patent Expirations: Generic Drugs and Active Ingredient Producers from the Perspective of ...

1

2

3